Valsartan Tablet
Product Images NDC 53401-029

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Valsartan (NDC 53401-029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (53401 0029 81)

Valsartan USP 80 mg oral tablets, package containing 1080 tablets. Label shows NDC 53401-029-81, storage instructions to keep between 20-25°C and dispense in a light-resistant container. Manufactured by Amneal Pharmaceuticals LLC, Brookhaven, NY and repackaged by Aphena Pharma Solutions - Tennessee, LLC, Cookeville, TN. Label marked RX only.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

F9674dc4-figure-01 (Valsartan Tablets Usp 1)

Chemical structure diagram of Valsartan, showing the molecular arrangement of atoms in the active ingredient Valsartan.*

FDA Label Image

1 (Valsartan Tablets Usp 2)

A forest plot titled 'Effects on Mortality Amongst Subgroups in VALIANT' comparing mortality effects of Valsartan versus Captopril. The plot displays subgroups by age, gender, race, geography, and beta-blocker use, with points and confidence intervals showing relative favorability between Valsartan and Captopril on a scale from 0.5 to 1.5.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.